John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Rio Tinto
RIO
$170B
| $6.69M | 0.02% |
88,914
-1,228,913
| -93% | -$80.7M |
|
|
WNS
777
DELISTED
WNS Holdings
WNS
| $6.68M | 0.02% |
92,739
+84,069
| +970% | +$5.64M |
|
|
OSB
778
DELISTED
Norbord Inc.
OSB
| $6.65M | 0.02% |
153,960
+88,223
| +134% | +$3.23M |
|
779
Oneok
OKE
$58.6B
| $6.63M | 0.02% |
172,820
-2,100,192
| -92% | -$70.6M |
|
780
CALL
Spotify
SPOT
$111B
| $6.61M | 0.02% |
21,000
+13,000
| +163% | +$3.67M |
|
|
PRVB
781
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $6.58M | 0.02% |
388,701
-161,631
| -29% | -$2.42M |
|
782
CALL
ExxonMobil
XOM
$675B
| $6.58M | 0.02% |
159,700
-7,600
| -5% | -$285K |
|
783
PUT
Coca-Cola
KO
$396B
| $6.58M | 0.02% |
120,000
-86,000
| -42% | -$4.45M |
|
784
PUT
Occidental Petroleum
OXY
$60.1B
| $6.54M | 0.02% |
378,000
-317,400
| -46% | -$4.35M |
|
|
SFIX
785
PUT
Stitch Fix
SFIX
$439M
| $6.54M | 0.02% |
111,300
+17,500
| +19% | +$749K |
|
|
OPLN
786
Openlane
OPLN
$4.16B
| $6.49M | 0.02% |
348,977
+123,869
| +55% | +$2.14M |
|
787
CALL
DexCom
DXCM
$34.4B
| $6.47M | 0.02% |
70,000
-38,400
| -35% | -$3.43M |
|
788
TriNet
TNET
$3.19B
| $6.47M | 0.02% |
80,275
+1,717
| +2% | +$127K |
|
789
PUT
Carvana
CVNA
$79.5B
| $6.44M | 0.02% |
134,500
+68,500
| +104% | +$3.13M |
|
790
LivePerson
LPSN
$33.2M
| $6.43M | 0.02% |
6,886
+3,753
| +120% | +$3.23M |
|
791
CALL
Etsy
ETSY
$7.99B
| $6.41M | 0.02% |
36,000
-26,400
| -42% | -$3.97M |
|
|
CBAY
792
DELISTED
Cymabay Therapeutics
CBAY
| $6.4M | 0.02% |
1,115,477
+870,584
| +355% | +$6.59M |
|
793
PUT
Dick's Sporting Goods
DKS
$16.1B
| $6.37M | 0.02% |
113,300
+96,100
| +559% | +$5.48M |
|
|
BCOV
794
DELISTED
Brightcove, Inc.
BCOV
| $6.36M | 0.02% |
345,541
+188,742
| +120% | +$2.69M |
|
795
CALL
Workhorse Group
WKHS
$34.1M
| $6.32M | 0.02% |
107
+100
| +1,429% | +$6.5M |
|
796
Twist Bioscience
TWST
$8.83B
| $6.31M | 0.02% |
44,643
+9,766
| +28% | +$1.08M |
|
797
Align Technology
ALGN
$11.3B
| $6.28M | 0.02% |
+11,745
| New | +$5.28M |
|
798
Merit Medical Systems
MMSI
$5.39B
| $6.26M | 0.02% |
112,864
+51,628
| +84% | +$2.66M |
|
799
CALL
RH
RH
$2.71B
| $6.26M | 0.02% |
14,000
+11,300
| +419% | +$4.66M |
|
|
WORK
800
CALL
DELISTED
Slack Technologies, Inc.
WORK
| $6.26M | 0.02% |
148,300
-201,800
| -58% | -$6.82M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.